Catherine Arendt
Catherine Arendt publishes mostly in Immunology, Rheumatology and Pathology and Forensic Medicine, on topics such as Psoriasis: Treatment and Pathogenesis, Autoimmune Bullous Skin Diseases and Pharmaceutical studies and practices.
- World rank
- #3,349,023 of 7,710,434 ranked researchers
- Rank in Belgium
- #30,226 of 67,186
- Works
- 38
- Citations
- 603
- Citations per work
- 15.9
What does Catherine Arendt research?
Catherine Arendt's work is mostly in Medicine (39%), Immunology and Microbiology (23%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1538.7%
- Medicine1538.7%
- Everything else1333.4%
- Life Sciences922.5%
- Social Sciences25.4%
- 1Immunology22% of their works
- 2Rheumatology16% of their works
- 3Pathology and Forensic Medicine9% of their works
- 4Pediatrics, Perinatology and Child Health8% of their works
- 5Oncology5% of their works
- 6Economics and Econometrics5% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Autoimmune Bullous Skin Diseases
- Pharmaceutical studies and practices
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Monoclonal and Polyclonal Antibodies Research
- Retinoids in leukemia and cellular processes
Which keywords describe Catherine Arendt's research?
The keywords of their largest research topics: IL-17, TH17 Cells, Autoantibodies, Pemphigoid, Rituximab, Inflammation, Off-Label Drug Use and Pediatric Pharmacokinetics.
- Acute Promyelocytic Leukemia
- Fc Receptors
- Quality of Life
- Ankylosing Spondylitis
- Pediatric Pharmacokinetics
- Inflammation
- Pemphigoid
- TH17 Cells
- IL-17
- Autoantibodies
- Rituximab
- Off-Label Drug Use
- Rheumatoid Arthritis
- Cost-effectiveness Analysis
- Spondyloarthritis
- Therapeutic Antibodies
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- IL-17231 topic
- TH17 Cells231 topic
- Autoantibodies172 topics
- Pemphigoid91 topic
- Rituximab91 topic
- Inflammation81 topic
- Off-Label Drug Use81 topic
- Pediatric Pharmacokinetics81 topic
- Rheumatoid Arthritis81 topic
- Ankylosing Spondylitis61 topic
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
- Spondyloarthritis61 topic
- Fc Receptors51 topic
- Therapeutic Antibodies51 topic
- Acute Promyelocytic Leukemia31 topic
- Retinoic Acid31 topic
Where does Catherine Arendt work?
Catherine Arendt's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Catherine Arendt have?
OpenAlex counts 38 works and 603 citations for Catherine Arendt, an h-index of 8, ranking #3,349,023 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Catherine Arendt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.